Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: United Kingdom Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20131
20152
20161
20181
20194
20211
20223
20234
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting6
Terminated6
Completed4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Genmab2
BicycleTx Limited1
Cancer Research UK1
Eisai Inc.1
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1
Grey Wolf Therapeutics1
Janssen Research & Development, LLC1
Kymab Limited1
Merus B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck23
Carcinoma, Non-Small-Cell Lung10
Stomach Neoplasms8
Triple Negative Breast Neoplasms8
Colorectal Neoplasms6
Esophageal Neoplasms6
Uterine Cervical Neoplasms6
Head and Neck Neoplasms4
Melanoma4
Neoplasm Metastasis4

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.